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SUMMARY
Purpose: Childhood convulsive status epilepticus (CSE), in particular prolonged febrile seizures (PFS), has been linked
with mesial temporal sclerosis (MTS). Previous studies have shown that hippocampal injury occurs in the acute phase
immediately followingCSE, but little is known about the longer term evolution of such injury. This study aimed to inves-
tigate the longer term outcome of childhood CSE with sequential magnetic resonance imaging (MRI) looking for pro-
gressive hippocampal injury during the first year post-CSE.
Methods: Eighty children (0.18–15.5 years) underwent brain MRI 1 month post-CSE, 50 with a repeat MRI at 6 months
and 46 with repeat MRI at 12 months post-CSE. Thirty-one control subjects without neurologic problems had a single
brain MRI for comparison. Hippocampal volumes were measured from each MRI scan by two independent observers,
and hippocampal growth rates were estimated in each patient with suitable imaging.
Key Findings: Hippocampal volume loss was found in 20–30% of patients and was not associated with the etiology or
clinical features of CSE, including seizure duration or focality. A borderline association was found between a history of
previous seizures (p = 0.063) and the number of previous febrile seizures (p = 0.051), suggesting that multiple insults
may be important in the pathogenesis of progressive hippocampal injury.
Significance: It is apparent that progressive hippocampal damage can occur after CSE of any etiology and is not limited
to PFS. Repeated seizures may play an important role, but further follow-up is needed to determine any other risk fac-
tors and proportion of children showing initial volume loss progress to clinical MTS and temporal lobe epilepsy.
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Prolonged seizures have long been linked with mesial
temporal sclerosis (MTS), the most common pathology seen
in patients with temporal lobe epilepsy (TLE; Grattan-
Smith et al., 1993). Around 30–50% of patients with intrac-
table TLE secondary to MTS have had an episode of child-
hood convulsive status epilepticus (CSE; Cavanagh &
Meyer, 1956; Harvey et al., 1995), and childhood prolonged
febrile seizures (PFS) in particular, where CSE occurs in a
neurologically normal child during a febrile illness, have
been specifically identified as a potential causative factor
for MTS (Cascino, 1995; Maher &McLachlan, 1995).
Case reports have suggested that prolonged seizure activ-
ity can be associated with brain injury, including progres-
sive hippocampal damage, ultimately leading to MTS
(Pohlmann-Eden, 2004). CSE is a relatively common condi-
tion in children, with an incidence of 17–23/100,000 chil-
dren per year (Chin et al., 2006); hence this has potentially
serious implications for medical care. It is therefore impor-
tant to systematically address this issue to assess the risks.
Studies performing magnetic resonance imaging (MRI)
in children in the first few days following PFS have consis-
tently shown acute increases in hippocampal volume and
hyperintensities on T2-weighted sequences (VanLanding-
ham et al., 1998; Scott et al., 2002; Natsume et al., 2007;
Shinnar et al., 2012). These are interpreted as representing
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acute hippocampal edema. The longer term evolution of
these acute changes is less well characterized, and in partic-
ular how or whether they are associated with MTS remains
unclear (Tarkka et al., 2003).
Follow-up imaging of children with PFS has shown that
initial increases in hippocampal volume and T2 relaxation
time resolve over time (VanLandingham et al., 1998; Scott
et al., 2003; Provenzale et al., 2008), but that increased hip-
pocampal asymmetry (Scott et al., 2003; Farrow et al.,
2006) or unilateral volume loss (Provenzale et al., 2008)
may occur in some children. The present study was designed
to prospectively investigate hippocampal changes in a new
cohort of children with CSE over the initial year post-CSE
and estimate the effect of CSE on subsequent hippocampal
growth. Investigations were targeted to characterize hippo-
campal growth from 1 month to 1 year following the epi-
sode of CSE and avoiding the period immediately following
CSE to prevent confounding from the previously demon-
strated acute changes. We hypothesized that by repeating
hippocampal measurements at multiple time points over the
year, evolving loss of hippocampal volume prior to the
development of clinical MTS and TLE would be detected.
A secondary hypothesis was that this would be specific to
children with PFS and not those with other forms of CSE.
Materials and Methods
Between 2007 and 2010, a cohort of 80 children was
recruited from hospitals in the North Thames health region,
London, United Kingdom, following an episode of CSE
(defined as a convulsive seizure or series of seizures lasting
longer than 30 min without recovery of consciousness). The
study was approved by the Great Ormond Street Hospital
(GOSH) research ethics committee.
Enrolled children were seen at GOSH for an assessment,
including detailed clinical review and MRI investigations
1 month after the acute episode. MRI investigations were
performed with the child awake, in natural sleep, under
sedation, or under general anaesthesia as appropriate for the
age and developmental stage of the child. These investiga-
tions were repeated at 6 and 12 months after the initial
episode of CSE.
Patients were divided into PFS and non-PFS groups for
analysis, where PFS was defined as an episode of CSE
occurring in a previously neurologically healthy child, asso-
ciated with a fever >38°C, in the absence of defined central
nervous system infection.
Twelve healthy volunteers and 19 children having MRI
scans for other clinical reasons, including dermatologic or
ophthalmic lesions, with no previous history of seizures and
no reported developmental or neurologic problems, were
recruited as controls. All volunteers were scanned either
awake or during natural sleep. Children who showed intra-
cranial lesions on their radiologic report were excluded
from the control group. Unlike children with CSE, who had
repeated assessments, each control only had a single MRI
investigation as: (1) repeating the general anesthesia or
sedation for those children who were having MRI for clini-
cal reasons would not have been ethical and (2) repeating an
MRI scan on those young controls that had their MRI during
postprandial natural sleep 1 year later would have required
sedation. All MRI investigations were performed on the
same 1.5-T scanner (Avanto; Siemens, Erlangen, Germany)
using a protocol including a T1-weighted three-dimensional
Fast Low Angle Shot (3D-FLASH) sequence (repetition
time (TR) = 4.94 msec, echo time (TE) = 11 msec, acqui-
sition matrix 256 9 224, in-plane resolution
1.0 9 1.0 mm, slice thickness 1 mm).
Hippocampal and intracranial volumemeasurement
Quantitative measurement of hippocampal volumes was
performed using the images obtained from 3D-FLASH
sequences. Using MRIcroN (http://www.mccauslandcenter.
sc.edu/mricro/mricron/index.html), regions of interest
(ROIs) were drawn manually on successive coronal slices,
using axial and sagittal views for further refinement, to
encompass the entire hippocampus. The anatomic limits of
the hippocampus were defined using the description given
by Gousias et al. (2008; Hammers et al., 2003). This was
performed separately by two individual observers (MY and
MM), blinded to the clinical status of the child, and mea-
surements were averaged for analysis.
The brain extraction tool (BET) in FSL (Analysis Group,
FMRIB, Oxford, United Kindgom) was used to segment
brain from skull and overlying tissue and to calculate intra-
cranial volume (ICV). Each image was manually inspected
by one researcher (MY) and manually adjusted to minimize
segmentation errors.
Statistics
All statistical analyses were performed with SPSS for
Windows version 19.0 (Chicago, IL, U.S.A.). p < 0.05 was
taken as the cutoff for significance, and Bonferroni correc-
tions for multiple comparisons were made where appropri-
ate. Reliability of hippocampal measurements was assessed
using averaged measurements from each individual obser-
ver to calculate the coefficient of variation (CoV) for intra-
rater and interrater measurements.
Cross-sectional comparison between the control group
and patients at each time point was performed using univari-
ate analysis of variance (ANOVA) with ICV as a covariate.
The same control group was used for each comparison.
Because for ethical and practical reasons longitudinal
measurements were not available on control children, it was
not possible to directly compare growth rates in patients and
controls. In patients with CSE, linear regression was used to
estimate left and right hippocampal growth rates over the
study period for those who had one or more follow-up scans.
The 95% confidence interval (CI) of this estimate was cal-
culated, and patients with the upper limit of this CI below 0,
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were considered to have “definite” loss of hippocampal vol-
ume. The control sample was modeled using a negative
decay curve in order to confirm that on a group basis hippo-
campi should increase in size over the age range of our
patients. Therefore, we have taken a conservative approach
to inference by only considering patients with a CI for
growth of <0 as having impairment in hippocampal growth.
Linear and logistic regression was used to explore the
influence of baseline clinical factors on hippocampal
growth.
Results
Demographics
A total of 225 children with CSE were identified as eli-
gible to take part in the study, 80 of whom were enrolled
and underwent initial MRI investigations. Of those who
were not enrolled, 35 children could not be contacted
owing to missing or incorrect contact details; 38 children
were unsuitable for MRI under sedation owing to instabil-
ity of their clinical condition/comorbidities; 48 children
declined to participate; 15 children who lived distant to the
study area were not willing to visit our center; and 7 chil-
dren died during their acute hospital admission. An addi-
tional two children agreed to participate but did not attend
their appointments. Because these children were not seen
for assessment and so did not consent to participate in the
study, only minimal demographic details were available,
and a comparison of clinical features of these children and
those enrolled was not possible. They did not differ signifi-
cantly from participants in age (mean age 3.8 vs. 3.2 years;
t-test; p = 0.175) or sex (male-to-female ratio 39:41 vs.
85:60; chi-square, p = 0.154). There was a difference in
etiologic composition, with children acute symptomatic
CSE forming 15.8% of those referred, but only 3.5% of
those enrolled (chi-square, p < 0.001).
There were 33 children with PFS and 47 with non-PFS
CSE. These comprised 22 patients with symptomatic epi-
lepsy, 21 with idiopathic/genetic epilepsy, and 4 who pre-
sented with a first episode of afebrile CSE with no previous
seizures. Their demographic and clinical details are summa-
rized in Table 1. Children with non-PFS were more likely
than children with PFS to have had focal CSE (chi-square,
p = 0.046), previous seizures (chi-square, p < 0.001), or a
previous episode of CSE (chi-square, p = 0.001). There
were no statistically significant between-group differences
in median age or seizure duration (Mann-Whitney U,
p = 0.077 and p = 0.652, respectively). There were no sig-
nificant differences between patients who attended one,
two, or three scans with respect to age, seizure duration, or
any other clinical factors. The numbers of patients available
at each follow-up are summarized in Table 2.
Hippocampal volumes after CSE
The mean interrater CoV for hippocampal volumetry was
6.27% and intrarater CoV was 5.19% (MY)/7.88% (MM)
for each observer, respectively. These values are consistent
with reported values from a sample of published studies
(Jack et al., 1990; Obenaus et al., 2001; Gousias et al.,
2008) and were considered adequate to proceed with further
analysis.
On cross-sectional analysis after correction for ICV, chil-
dren with CSE did not have significantly different hippo-
campal volumes from controls at any time point (ANOVA,
p > 0.1; Table 3).
Hippocampal growth over time
Forty-nine children attended the second assessment, and
a further 11 children attended a third scan (but not the sec-
ond); therefore, 60/80 children underwent at least two
assessments and were able to have hippocampal growth
rates estimated. Fifteen 60 (25%, 95% confidence interval
[CI] 15.7–37.2%) showed definite decreases in hippocam-
pal volume. They were split between PFS (5/26) and non-
PFS (10/34) groups as shown in Table 4. A summary of the
Table 2. Patient numbers at each follow-up assessment
PFS Non-PFS Overall
1st MRI scan 33 47 80
2nd MRI scan 21 29 50
3rd MRI scan 21 25 46
Table 1. Demographics and seizure characteristics of cohort
PFC (n = 33) Non-PFS CSE (n = 47) Overall (n = 80) Controls (n = 31)
Median age/years (range) 1.86 (0.80–4.61) 2.40 (0.18–15.50) 2.28 (0.18–15.50) 3.03 (0.21–12.69)
Male-to-female ratio 10:23 29:18 39:41 12:19
Median time to first scan/days (range) 37 (5–90) 22 (7–66) 29.5 (5–90)
Mean time to first scan/days (SD) 37.8 (20.2) 27.5 (15.6) 31.8 (18.2)
Focal onset (%) 5 (15.2) 18 (38.3) 23 (29.1)
Continuous seizure activity (%) 20 (61) 26 (55) 46 (57)
Intermittent seizure activity (%) 13 (39) 21 (45) 54 (43)
Mean seizure duration in minutes (range) 71.67 (30–190) 92.9 (30–265) 72.40 (30–265)
Previous seizures (%) 12 (36) 36 (77) 48 (60)
Previous episode CSE (%) 2 (6) 19 (40) 21 (26)
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clinical details of each patient with volume loss is available
online (Table S1). The mean reduction in hippocampal vol-
ume found was 398 mm3 (standard deviation [SD]
261 mm3), representing 17% of initial hippocampal vol-
ume. 4/5 of the children with PFS showed unilateral loss,
whereas only 5/10 of those with non-PFS CSE did. Figure 1
shows left and right hippocampal volumes over time for the
entire cohort, with those patients showing a definite
decrease highlighted with solid lines.
Predictive factors for hippocampal volume loss
There was no statistically significant difference in the
proportion of children with definite volume loss in PFS/
non-PFS groups (p = 0.26, chi-square).
Linear regression did not show any significant associa-
tion between hippocampal growth rates (left/right) and a
number of clinical factors, including the following: seizure
duration (p = 0.150/0.425); focal versus generalized CSE
(p = 0.253/0.124); continuous versus intermittent CSE
(p = 0.941/0.742); history of CSE (p = 0.150/0.096); or
number of previous seizures (p = 0.948/0.541). Each factor
was entered individually into the regression model (p-values
quoted) and in all two-factor combinations, with no signifi-
cant associations found. Logistic regression was also per-
formed using a definite decrease in hippocampal volume as
the outcome, and the same predictors and did not show any
significant associations, although there was a borderline
association between volume loss and a history of previous
seizures (p = 0.063, odds ratio [OR] 3.56; 95% CI 0.93–
13.8). Older children were more likely to show volume loss
(p = 0.003, OR 1.31; 95% CI 1.01–1.55); however, this is
confounded by the fact that younger children would be
expected to be growing at a fast rate, and therefore, less
likely to show volume loss, even if growth failure did occur.
Regression analysis on the PFS group alone showed that
the number of previous febrile seizures had a significant
negative association with left hippocampal growth
(p < 0.001; B = 76.68; 95% CI 111.16 to 42.20) and
that children who showed a definite decrease in hippocam-
pal volume were more likely to have had previous febrile
seizures (p = 0.051, OR 1.75; 95% CI 1.00–3.06). No asso-
ciations were found with other clinical factors.
Thirty-one of 80 children experienced seizure recur-
rence during the follow-up period, of which 6 had a fur-
ther episode of CSE. Recurrent seizures were not
associated with a definite decrease in hippocampal vol-
ume, but there was a borderline association between hip-
pocampal volume loss and repeated CSE (p = 0.079, OR
4.61; 95% CI 0.84–25.5).
Discussion
To our knowledge this is the first study to show that hippo-
campal volume loss occurs in a significant proportion of chil-
dren following all types of CSE and not only in those who
have PFS, as most previous studies have not included children
with etiologies other than PFS. This is important because
although attention has focused on PFS as a risk factor for
MTS, it suggests that similar consideration needs to be paid to
the possibility of hippocampal damage in other forms of CSE.
Although previous observations did not distinguish
between different causes of CSE (Meyer et al., 1954), later
studies have suggested a specific relationship between
MTS and childhood PFS (French et al., 1993; Kuks et al.,
1993), although associations with other neurologic insults
such as bacterial meningitis have also been reported (Har-
vey et al., 1995).
If childhood CSE directly causes the development of
MTS, progressive volume loss should be a necessary step in
the transformation of a normal hippocampus into a sclero-
sed and epileptogenic one. Although it cannot be assumed
that all children showing early volume loss will progress
further to clinical MTS, it seems biologically implausible
that those who are not showing signs of altered hippocampal
Table 3. Mean adjusted hippocampal volumes at 1, 6, and 12 months post-CSE
Time point Side
Mean hippocampal volumes (mm3) (95%CI) after adjustment for ICV
PFS Non-PFS Controls
1 month Left 1,942 (1,856–2,028) 1,862 (1,790–1,934) 1,975 (1,886–2,064)
Right 2,046 (1,952–2,140) 1,943 (1,864–2,021) 2,083 (1,986–2,180)
6 months Left 1,980 (1,870–2,088) 1,911 (1,819–2,004) 2,062 (1,972–2,152)
Right 2,167 (2,039–2,295) 1,930 (1,822–2,039)* 2,175 (2,070–2,281)
12 months Left 2,052 (1,939–2,165) 1,895 (1,796–1,994)* 2,077 (1,984–2,170)
Right 2,202 (2,053–2,351) 1,994 (1,864–2,125) 2,188 (2,065–2,310)
*Significantly different from control values p < 0.05.
Table 4. Proportion of children showing definite
hippocampal volume loss
No. children
with two or
more MRI scans
No. showing
definite volume loss (%)
Prolonged febrile seizures 26 5 (19.2)
Non-PFS CSE 34 10 (29.4)
Total 60 15 (25.0)
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growth will go on to develop MTS as a result of this episode
of CSE if no signs of this process are detectable in the first
year. Therefore, around 25% of children with CSE are likely
to be at risk of developingMTS, but further study is required
to determine how many of these children will ultimately
develop TLE.
Given the finding that hippocampal volume loss occurs
in similar, if not greater frequency after non-PFS CSE, it is
A
B
Figure 1.
Left (A) and right (B) hippocampal growth in the year following CSE. Children showing definite hippocampal volume loss are shown with
solid lines.
Epilepsia ILAE
Epilepsia, 54(12):2108–2115, 2013
doi: 10.1111/epi.12426
2112
M. Yoong et al.
unclear why this is not also associated with MTS/TLE.
One possibility is that MTS is underdiagnosed in patients
with non-PFS CSE. Diagnosing MTS requires specific
MRI sequences that are optimized to detect hippocampal
pathology, which may not have been available in historical
cases (Geuze et al., 2005). Furthermore, MRI may not
always be performed in these patients as patients with idio-
pathic epilepsy or a known symptomatic cause for their sei-
zures are unlikely to have repeated MRI unless there is an
unexpected clinical deterioration, especially given the chal-
lenges of performing this in children with a high burden of
neurodisability.
Alternatively differences in the pathology of the underly-
ing conditions may mean that, although the initial hippo-
campal injury is similar in all forms of CSE, the longer term
course differs. Although studies of adults with chronic epi-
lepsy have shown that between 10% and 20% show hippo-
campal volume loss on longitudinal MRI (Liu et al., 2005;
Salmenper€a et al., 2005) that does not appear to be associ-
ated with MTS, data from animal studies suggest that preex-
isting neuronal abnormalities or insults are likely to increase
rather than decrease the vulnerability of the hippocampus to
further injury (Jensen et al., 1992; Lucas et al., 2011).
Only two other studies to date have reported longitudinal
measurements of hippocampal volumes after CSE in chil-
dren (Scott et al., 2003; Provenzale et al., 2008). In both
these studies, which only considered children with PFS, ini-
tial hippocampal volumes were measured within 3–5 days
of the PFS, with follow-up measurements months to years
later. It is known that patients imaged within this acute per-
iod show increased hippocampal volumes, thought to be
attributable to hippocampal edema (Scott et al., 2006).
Scott et al. (2003) interpreted a fall of 203 mm3 in mean
corrected hippocampal volumes in children with PFS
between initial MRI scan and follow-up at 4–8 months
post-CSE as the resolution of this edema, since hippocampal
volumes at follow-up were not significantly different from
control values. Provenzale et al. (2008) took initial mea-
surements at a similar time point, but had a longer period of
follow-up spanning 2–23 months post-CSE. They reported
absolute falls of 715–1,217 mm3 in uncorrected hippocam-
pal volumes in 3/11 children along with persistent abnormal
T2 signals, and smaller reductions in a further two children.
Because confounding by the hippocampal edema present in
the acute phase makes it difficult to interpret subsequent
falls in hippocampal volume, this study was designed so that
the initial measurements were made at a point when this
would be expected to have resolved. That the results from
our study are broadly in line with these previous studies,
demonstrates that the effect on hippocampal growth does
not simply represent resolution of the edema. It is important
to note that several children with definite volume loss had
final hippocampal volumes that lie within the normal range.
Therefore, cross-sectional studies are less likely to reveal
evidence for hippocampal abnormalities. This highlights
the importance of carrying out longitudinal studies to
address the issue of hippocampal injury following CSE.
The initial MRI findings in this cohort have been
reported previously (Yoong et al., 2012); one patient had
preexisting MTS and one patient met criteria for unilat-
eral hippocampal malrotation. None of the children with
PFS had hippocampal or extrahippocampal abnormalities
on their initial MRI, and none has developed unprovoked
seizures or MTS to date, although some have had recur-
rent febrile seizures. This loss of volume in a significant
proportion of children appears to represent a new and
progressive hippocampal injury: a potential precursor to
MTS over the longer term.
Limitations
There are a number of limitations that need to be
addressed when interpreting the results of this study. First,
as previously mentioned, direct comparison of growth rates
between patients and controls was not possible. Studies of
hippocampal growth in healthy children (Pfluger et al.,
1999; Utsunomiya et al., 1999; Gogtay et al., 2006; Knick-
meyer et al., 2008) have shown that the normal hippocam-
pus increases rapidly in size over the first 2 years of life and
more slowly thereafter; therefore, it seems reasonable to
conclude that a loss of hippocampal volume is pathologic at
this age. Our definition of “definite” volume loss is a con-
servative one, as growth failure may exist at this age range
without actual loss of volume.
Second, few children with acute symptomatic CSE took
part in the study and only one was able to undergo repeat
MRI. This was because a disproportionate number of patients
with acute symptomatic CSE declined consent or were not
able to take part due to the severity of their clinical condition.
As a result, the non-PFS group consists predominantly of
children with prior neurologic injuries and genetic/idiopathic
epilepsy. This necessarily limits the conclusions that can be
drawn about children with acute injuries.
Third, the use of linear regression to estimate growth rates
assumes that growth can be approximated by a linear func-
tion. Using a regression technique, with multiple measure-
ments by multiple observers reduces the effects of any
natural variability in hippocampal measurements, thereby
minimizing the risk of type 1 error, but means that children
whose hippocampus grows initially and only starts to lose
volume after 6 months may not have been detected.
Although we believe an immediate effect on growth is more
likely, it is not impossible that an unknown delayed patho-
logic process is important in the pathogenesis of MTS.
Despite these limitations, our study is the largest study of
childhood CSE of different etiologies and with longitudinal
follow-up at three time points within a year of initial CSE.
The lack of association between hippocampal growth and
any seizure-associated variables, suggests that there may
not be a simple relationship between seizure severity and
hippocampal damage.
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Despite previous studies that suggest an association
between seizure duration and MTS (Maher & McLachlan,
1995), we did not find any association between CSE dura-
tion and hippocampal volume loss, albeit all the children in
our cohort had seizures >30 min. We did find an association
between volume loss and previous febrile seizures, as well
as borderline associations with any previous seizures and
subsequent episodes of CSE, suggesting that “multiple hits”
may be required to cause lasting hippocampal damage and
that the number of significant events may be important in
the development of MTS. The lack of a significant dose–
response effect may be due to several patients who did not
show volume loss despite having recurrent seizures on a
weekly or daily basis, but further data are needed to draw a
definite conclusion.
Conclusion
We have demonstrated that approximately 20–30% of
children have definite hippocampal volume loss in the year
following CSE. In comparison to previous studies of hippo-
campal volume after CSE, we have achieved a more inten-
sive and more complete follow-up and included etiologies
of CSE other than PFS. This has shown that volume loss
after CSE is not limited to PFS, but occurs with equal, if not
greater frequency, in other forms of CSE.
There may be a role of repeated febrile seizures or
repeated episodes of CSE in the pathogenesis of long-term
hippocampal injury, but there does not appear to be a strong
association with any other clinical factors. Further identifi-
cation of specific risk factors for hippocampal volume loss
may be possible with larger cohorts of children with CSE,
such as the FEBSTAT study (Hesdorffer et al., 2012), but
for the present remains a challenge. It is apparent that there
is a risk of progressive hippocampal damage following CSE
and that this can occur after CSE of any etiology. Longer
term follow-up of this and other cohorts will be required to
determine the risks of this initial hippocampal volume loss
further progressing to clinical MTS, as well as clarifying the
association or lack thereof with non-PFS CSE.
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